4//SEC Filing
Goldan Keith A. 4
Accession 0001562180-23-005152
CIK 0001395937other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:20 PM ET
Size
4.9 KB
Accession
0001562180-23-005152
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-06-13$22.31/sh−577$12,873→ 2,628 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:20 PM ET
- Size
- 4.9 KB